6 reports

MABTECH LIMITED IS DEVELOPING BASILIXIMAB BIOBETTER (STI-##) FOR THE PROPHYLAXIS OF ACUTE ORGAN REJECTION IN PATIENTS RECEIVING KIDNEY TRANSPLANTATION.

  • Health Services
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Product Initiative

Kidney Transplant Rejection - Overview Kidney Transplant Rejection - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR KIDNEY TRANSPLANT REJECTION, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR KIDNEY TRANSPLANT REJECTION, H## 2018 Pre-Registration ## ## Ph

  • Healthcare
  • Therapy
  • Transplantation
  • United States
  • Product Initiative
  • GRAFT VERSUS HOST DISEASE (GVHD) - PIPELINE BY UNITED BIOPHARMA INC, H1 2018
  • GRAFT VERSUS HOST DISEASE (GVHD) - PIPELINE BY ABBVIE INC, H1 2018

The company provides products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobetter and biosuperior ADCs.

  • Healthcare
  • Medical Biotechnology
  • Transplantation
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG
  • Transplantation Therapeutics, Global, Pipeline Products, 2017 (Part 2)

Cytokine; ##(##): ##-## Joseph RW, et al. (2008).

  • General Medicine And Specialty Medicine
  • Immunotherapy
  • Medical Biotechnology
  • Transplantation
  • Deals & Alliance
  • BONE MARROW TRANSPLANT REJECTION - PIPELINE BY UNITED BIOPHARMA INC
  • GRAFT VERSUS HOST DISEASE (GVHD) - PIPELINE BY UNITED BIOPHARMA INC

The company' s products include pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobetter and biosuperior ADCs.

  • Cell Therapy
  • Healthcare
  • Therapy
  • Transplantation
  • Product Initiative